These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6764960)

  • 1. [Biological and clinical aspects of alpha 1-antitrypsin with special reference to malignant tumor processes].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1981; 28(4):591-641 contd. PubMed ID: 6764960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological and clinical aspects of alpha 1-antitrypsin with special reference to malignant tumor processes II].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1982; 29(1):77-127 contd. PubMed ID: 6199818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological and clinical features of alpha 1-antitrypsin with special reference to malignant processes. III].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1982; 29(2):325-66. PubMed ID: 6201961
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of alpha-1-antitrypsin in pancreatic islet cell tumors.
    Prinz RA; Sandberg L
    J Med; 1984; 15(3):177-83. PubMed ID: 6098624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
    Kovcić V; Jelić S; Filipović I; Tomasević Z
    Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of alpha-1-antitrypsin and alpha-2-pregnancy-associated glycoprotein in the serum of patients with bronchial carcinoma].
    Homolka J; Voslárová Z; Malbohan I
    Z Erkr Atmungsorgane; 1987; 169(1):38-43. PubMed ID: 3118584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alpha one antitrypsin in malignancy.
    Yemul VL; Kumthekar SN; Muley PR; Agrawal BR
    Indian J Cancer; 1987 Jun; 24(2):107-11. PubMed ID: 3500907
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of serpin (alpha-1-antitrypsin) as serum growth inhibitory factor in murine ehrlich carcinoma by proteomics.
    Donenko FV; Ziganshin RH; Anisimova NY; Voyushin KE; Sitdikova SM; Amandzholov BS; Kiselevskii MV; Efferth T
    Cancer Genomics Proteomics; 2010; 7(3):147-56. PubMed ID: 20551247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
    Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Normal values of alpha 1 antitrypsin in the mestizo Mexican population].
    Gaytan M; Martínez J; Vázquez L; Chapela R
    Arch Invest Med (Mex); 1989; 20(1):39-43. PubMed ID: 2788397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of alpha 1-antitrypsin in the serum of neoplasm patients].
    Fonseca Sánchez E; Chimpén Ruiz V; López Berges C; Fermoso García J; de Portugal Alvarez J
    Med Clin (Barc); 1983 Nov; 81(17):752-4. PubMed ID: 6606747
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal profile of serum proteinase inhibitors in cancer patients.
    Chawla RK; Rausch DJ; Miller FW; Vogler WR; Lawson DH
    Cancer Res; 1984 Jun; 44(6):2718-23. PubMed ID: 6722803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the serum alpha 1 antitrypsin (alpha 1 AT) in healthy people and patients with respiratory diseases].
    Mitsuyasu K; Oshima S
    Bull Chest Dis Res Inst Kyoto Univ; 1981 Mar; 14(1-2):15-21. PubMed ID: 6985429
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin after surgical treatment and during postoperative clinical course of human gastric cancer.
    Bernacka K; Kuryliszyn-Moskal A; Klimiuk PA
    Neoplasma; 1993; 40(2):111-6. PubMed ID: 7688868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha 1-antitrypsin as a tumor marker].
    Schena M; Quadri A; Ragazzoni G; Corti P
    Quad Sclavo Diagn; 1985 Mar; 21(1):87-96. PubMed ID: 3877314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum alpha-1-antitrypsin specific activity in monoclonal gammopathies.
    Jelić-Ivanović Z; Stanković B; Topić A; Spasojević-Kalimanovska V; Spasić S
    Panminerva Med; 2000 Mar; 42(1):17-21. PubMed ID: 11019599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantification of serum alpha-1-antitrypsin as a biological marker in cancer].
    Senra Valera A; Millán Núñez-Cortés J
    Rev Clin Esp; 1985 May; 176(8):406-9. PubMed ID: 3875123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.